Joe McCracken is Vice President of Business Development at Genentech, Inc.
In this role, McCracken is responsible for all business development activities at the company, including the identification and negotiation of collaboration and licensing agreements with academic institutions, biotechnology companies and pharmaceutical companies throughout the world. After a seven-year absence, McCracken rejoined Genentech in 2000 as Vice President of Business Development. During his earlier time with Genentech, McCracken served in many capacities, culminating in positions as Director of Business Development and Representative Director of Genentech Ltd., Genentech's wholly owned subsidiary in Japan.
McCracken has more than 19 years of experience in technical, business development and market development roles with biotechnology and pharmaceutical companies. He has also served as Vice President of Technology Licensing and Alliances at Aventis, and Vice Pr...
Click here to continuously play all of the videos from this speaker in a new window.
Description
Joe McCracken, Vice President of Business Development at Genentech, describes Genentech's business model where commercialization takes a back seat to science. He differentiates this from other typical pharmaceutical companies and shows how this affects the culture at Genentech. He credits this approach for the successful innovation of several hugely profitable drugs.